We are live on
!
Find out more
LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $5.44M | – | – | – |
|
2
Macquarie Group
Sydney, NSW 2000,
Australia
| $54K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $46.1K | – | – | – |
|
4
Renaissance Technologies
New York
| $41K | +$3.94K | +1,000 | +10% |
|
5
JP Morgan Chase
New York
| $216 | – | – | – |
|
6
BlackRock
New York
| $154 | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $154 | +$20 | +5 | +14% |
|
|
CPG
8
Cornerstone Planning Group
Fairfield,
New Jersey
| $44 | +$47 | +12 | New |
|
9
Wells Fargo
San Francisco,
California
| $37 | +$4 | +1 | +11% |
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$5K | -1,209 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | -$4.58K | -1,180 | Closed |
|